Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2013

Content (17 Articles)

Review

Paget’s disease of the nipple

Ana C. Sandoval-Leon, Katherine Drews-Elger, Carmen R. Gomez-Fernandez, Monica M. Yepes, Marc E. Lippman

Preclinical Study

Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis

Yan-Mei Wu, Wei Hu, Yang Wang, Ning Wang, Li Gao, Zhong-Zhong Chen, Wei-Qiang Zheng

Preclinical study

Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model

Bauke Anninga, Muneer Ahmed, Mieke Van Hemelrijck, Joost Pouw, David Westbroek, Sarah Pinder, Bennie ten Haken, Quentin Pankhurst, Michael Douek

Open Access Preclinical Study

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

Allan Lipton, Laurie Goodman, Kim Leitzel, Jennifer Cook, Jeff Sperinde, Mojgan Haddad, Wolfgang J. Köstler, Weidong Huang, Jodi M. Weidler, Suhail Ali, Alicia Newton, Eva-Marie Fuchs, Agnes Paquet, Christian F. Singer, Reinhard Horvat, Xueguang Jin, Joyee Banerjee, Ali Mukherjee, Yuping Tan, Yining Shi, Ahmed Chenna, Jeff Larson, Yolanda Lie, Thomas Sherwood, Christos J. Petropoulos, Stephen Williams, John Winslow, Gordon Parry, Michael Bates

Preclinical study

Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells

Angela Catania, Enrique Barrajón-Catalán, Silvia Nicolosi, Federico Cicirata, Vicente Micol

Preclinical Study

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling

Claudia Fumarola, Cristina Caffarra, Silvia La Monica, Maricla Galetti, Roberta R. Alfieri, Andrea Cavazzoni, Elena Galvani, Daniele Generali, Pier Giorgio Petronini, Mara A. Bonelli

Preclinical Study

Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment

Tuomas Heikkinen, Taina Korpela, Rainer Fagerholm, Sofia Khan, Kristiina Aittomäki, Päivi Heikkilä, Carl Blomqvist, Olli Carpén, Heli Nevanlinna

Clinical Trial

LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients

Sung Gwe Ahn, Seung Myung Dong, Akira Oshima, Woo Ho Kim, Hak Min Lee, Seung Ah Lee, Seung-hyun Kwon, Ji-hae Lee, Jae Myun Lee, Joon Jeong, Hy-De Lee, Jeffrey E. Green

Open Access Clinical Trial

Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

M. Campiglio, R. Bufalino, M. Sasso, E. Ferri, P. Casalini, V. Adamo, A. Fabi, R. Aiello, F. Riccardi, E. Valle, V. Scotti, G. Tabaro, D. Giuffrida, E. Tarenzi, A. Bologna, G. Mustacchi, F. Bianchi, A. Balsari, S. Ménard, E. Tagliabue

Clinical trial

The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study

Dominique Frechette, Lise Paquet, Shailendra Verma, Mark Clemons, Paul Wheatley-Price, Stan Z. Gertler, Xinni Song, Nadine Graham, Susan Dent

Clinical trial

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

Luigi Di Lauro, Patrizia Vici, Pietro Del Medico, Lucio Laudadio, Silverio Tomao, Diana Giannarelli, Laura Pizzuti, Domenico Sergi, Maddalena Barba, Marcello Maugeri-Saccà

Epidemiology

High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy

Penny Fang, Kay See Tan, Andrea B. Troxel, Ramesh Rengan, Gary Freedman, Lilie L. Lin

Epidemiology

Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests

P. Pujol, D. Stoppa Lyonnet, T. Frebourg, J. Blin, M. C. Picot, C. Lasset, C. Dugast, P. Berthet, B. Bressac de Paillerets, H. Sobol, S. Grandjouan, F. Soubrier, B. Buecher, R. Guimbaud, R. Lidereau, P. Jonveaux, C. Houdayer, S. Giraud, S. Olschwang, E. Nogue, V. Galibert, C. Bara, F. Nowak, D. Khayat, C. Nogues

Epidemiology

Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study

Brian L. Sprague, Vicki McLaughlin, John M. Hampton, Polly A. Newcomb, Amy Trentham-Dietz

Brief Report

Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer

Brigid K. Killelea, Jessica B. Long, Anees B. Chagpar, Xiaomei Ma, Pamela R. Soulos, Joseph S. Ross, Cary P. Gross

Erratum

Erratum to: DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study

Meng Hua Tao, Peter G. Shields, Jing Nie, Amy Millen, Christine B. Ambrosone, Stephen B. Edge, Shiva S. Krishnan, Catalin Marian, Bin Xie, Janet Winston, Dominica Vito, Maurizio Trevisan, Jo L. Freudenheim

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine